U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H25Cl2N3O3
Molecular Weight 450.358
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BRILAROXAZINE

SMILES

ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC=C4OCC(=O)NC4=C3)CC2

InChI

InChIKey=PMKMNTBZJOXTJW-UHFFFAOYSA-N
InChI=1S/C22H25Cl2N3O3/c23-17-4-3-5-19(22(17)24)27-11-9-26(10-12-27)8-1-2-13-29-16-6-7-20-18(14-16)25-21(28)15-30-20/h3-7,14H,1-2,8-13,15H2,(H,25,28)

HIDE SMILES / InChI

Molecular Formula C22H25Cl2N3O3
Molecular Weight 450.358
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:38:36 UTC 2023
Edited
by admin
on Sat Dec 16 10:38:36 UTC 2023
Record UNII
X8L60BA01I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BRILAROXAZINE
INN  
Official Name English
6-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-2H-BENZO(B)(1,4)OXAZIN-3(4H)-ONE
Systematic Name English
Brilaroxazine [WHO-DD]
Common Name English
brilaroxazine [INN]
Common Name English
2H-1,4-BENZOXAZIN-3(4H)-ONE, 6-(4-(4-(2,3-DICHLOROPHENYL)-1-PIPERAZINYL)BUTOXY)-
Systematic Name English
6-(4-(4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL)-BUTOXY)-2H-BENZO(B)(1,4)OXAZIN-3(4H)-ONE
Systematic Name English
RP-5063
Code English
Code System Code Type Description
CAS
1239729-06-6
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
DRUG BANK
DB09226
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
SMS_ID
100000183563
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
EPA CompTox
DTXSID001136921
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
WIKIPEDIA
RP5063
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
NCI_THESAURUS
C169817
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
FDA UNII
X8L60BA01I
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
PUBCHEM
46861612
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
CAS
2036070-48-9
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
NO STRUCTURE GIVEN
INN
10819
Created by admin on Sat Dec 16 10:38:36 UTC 2023 , Edited by admin on Sat Dec 16 10:38:36 UTC 2023
PRIMARY
Related Record Type Details
TARGET->PARTIAL AGONIST
Ki
METABOLIC ENZYME -> SUBSTRATE
MAJOR
TARGET -> INHIBITOR
Ki
TARGET -> INHIBITOR
Ki
TARGET->PARTIAL AGONIST
Ki
TARGET->PARTIAL AGONIST
Ki
TARGET -> INHIBITOR
Ki
SALT/SOLVATE -> PARENT
TARGET->PARTIAL AGONIST
Ki
TARGET->PARTIAL AGONIST
Ki
METABOLIC ENZYME -> SUBSTRATE
MINOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC DOSE
PHARMACOKINETIC
ROUTE OF ADMINISTRATION
PHARMACOKINETIC
Tmax PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC
DOSE
PHARMACOKINETIC
Cmax PHARMACOKINETIC ROUTE OF ADMINSTRATION
PHARMACOKINETIC
DOSE
PHARMACOKINETIC